This therapy uses a radioactive substance called a radionuclide. It is injected into the bloodstream. Cancer cells absorb the radionuclide more than normal cells. This means they receive a higher dose of radioactivity. This eventually destroys the cancer cells.
To control the growth of NETs, the radionuclide can be combined with a substance called octreotide or MIBG. The NET cells absorb the drug along with the radioactive substance.
If the treatment uses octreotide, it is sometimes called peptide receptor radionuclide therapy (PRRT).
Targeted radionuclide therapy only works for NETs that absorb large amounts of octreotide or MIBG. So before treatment, you will have a scan. The scan will measure how much octreotide or MIBG the tumour absorbs.
After the radionuclide therapy, you will need to be in a room by yourself for a few days. This is so the radiation cannot affect others, especially children and pregnant women. Your nurse will give you more information about this.
Some people get a tummy ache or feel sick because of the treatment. Medicines can help with this. There may be a temporary drop in some of your blood cell levels. If this happens, you may feel tired, be more at risk of infection, or bruise or bleed more easily. But doctors will monitor you closely.
For most people, the side effects do not last long and they recover quickly.